Edible Cannabis Poses Hidden Driving Risk Below Legal THC Limits

A new study from Toronto reveals a troubling gap in how authorities detect impaired driving: people who eat cannabis edibles show significant driving problems—worse lane control, slower reaction times, erratic speed—while their blood tests register THC levels nearly ten times lower than smokers with similar impairment. The research, published in JAMA Network Open, exposes a blind spot in enforcement that could affect road safety across Canada and parts of the United States where legal THC thresholds are used to prosecute impaired driving.

The Centre for Addiction and Mental Health recruited 40 regular cannabis users for a controlled trial. Each person attended four separate sessions and consumed soft-chew gummies containing either no THC, 2 milligrams, 10 milligrams, or 20 milligrams. Researchers then placed them in a driving simulator at two, five, and 24 hours after consumption, measuring how well they maintained their lane position, how quickly they reacted to road events, and how consistently they controlled speed. Blood samples were drawn and participants rated their own sense of intoxication.

The findings were clear. At two and five hours after consuming the 10- and 20-milligram doses, drivers showed measurable impairment compared to placebo. Those who took 20 milligrams had noticeably slower reaction times and less stable speed control. Lane position became erratic. The drivers themselves felt it—they reported lower confidence in their ability to drive and said they would be less willing to get behind the wheel. Yet when researchers measured their blood, the highest concentrations averaged just 1.6 nanograms per milliliter for the 10-milligram dose and 3.4 nanograms per milliliter for the 20-milligram dose. Both fell below the 5-nanogram threshold commonly used in legal enforcement, though some individual samples did cross that line.

The contrast with smoked cannabis is stark. In an earlier study by the same team, people who smoked cannabis and showed similar levels of driving impairment had peak blood THC concentrations averaging 30.3 nanograms per milliliter—nearly ten times higher than the edible group. The difference lies in how the body processes each form. Smoking delivers THC rapidly into the bloodstream, spiking levels quickly. Edibles are absorbed slowly through the digestive system, producing a delayed and prolonged effect that can impair driving even as blood concentrations remain low.

Dr. José Ignacio Nazif-Munoz of the Université de Sherbrooke, writing in an accompanying commentary, flagged the enforcement problem directly. Standard blood tests, he noted, may fail to identify drivers who are genuinely unsafe because of the biological differences between smoked and eaten cannabis. Policymakers are now searching for more reliable roadside tools—tests that can catch impairment without relying solely on blood THC numbers that may not reflect actual driving risk.

The study does carry limitations. All driving tests were conducted on simulators rather than real roads, so drivers faced no actual physical danger. The research focused on regular cannabis users, leaving unclear how occasional users might respond to the same doses. And by 24 hours after consumption, residual effects largely disappeared, though maximum speed remained slightly elevated in the 10- and 20-milligram groups even as subjective feelings of intoxication had completely faded.

What remains unresolved is how law enforcement will adapt. As cannabis edibles become more common and more jurisdictions legalize cannabis, the gap between what blood tests can detect and what actually impairs driving becomes a public safety question with no easy answer.